Radiotherapy in the management of thyroid cancer

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 3, 1996, Pages 413-419

  Harmer, C L ^a,b  

^a Royal Marsden Hospital   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

external beam irradiation; iodine 131; local control; physical and biological optimisation; treatment strategy

Indexed keywords

IODINE 131;

CANCER RADIOTHERAPY; HUMAN; LYMPHOMA; REVIEW; THYROID CANCER; THYROID CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ANAPLASIA; CALCITONIN; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; LYMPHOMA; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PALLIATIVE CARE; PROGNOSIS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 0029789986     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Rosai J, Carcangiu M L, Delellis R A. Atlas of Tumor Pathology Tumors of the Thyroid Gland Third Series Fascicle 5 Washington D C:Armed Forces Institute of Pathology, 1992:90.
2. Hay I D, Bergstralh E J, Ebdersold J R, Grant C S, van Heerden J A, Goellner J R Papillary thyroid carcinoma ≤1 5 cm diameter: Woolner's "occult" tumour revisited [abstract]. J Endocrinol Invest 1992; 15(Suppl 2).32.
3. Clark O H Treatment of choice for patients with differentiated thyroid cancer Ann Surg 1982; 196:361-8
4. Harmer C Thyroid cancer. In: Horwich A, editor. Oncology: A Multidisciplinary Textbook. London Chapman & Hall Medical, 1995:565-84.
5. Savoie J C, Massin J P, Leger A F, Djemli F K, Caillon R, Aurengo A. Outcome of differentiated thyroid cancer after long-term follow-up: 1000 cases In Jaffiol C, Milhaud G, editors. Thyroid Cancer. The Netherlands Elsevier Science, 1985:209-17.
6. Powell S, Harmer C L. Death from thyroid cancer after forty years: rationale for initial intensive treatment. Eur J Surg Oncol 1990; 16:457-61.
7. Sarker S D, Beierwaltes W H, Gill S P, Cowley B J. Subsequent fertility and birth histories of children and adolescents treated with I-131 for thyroid cancer. J Nucl Med 1976; 17 460-4
8. Edmonds C J, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59:45-51.
9. Harmer C L. Multidisciplinary management of thyroid neoplasms. In. Preece P E, Rosen R D, Maran A G D, editors. Head and Neck Oncology for the General Surgeon. London: W B Saunders, 1991:55-90
10. Mazaferri E L, Jhiang S M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97 418-28.
11. Pochin E E. Radioiodine therapy of thyroid cancer. Semin Nucl Med 1971: 4:503-15.
12. Charbord P, L'Heritier C, Cukersztein W, Lumbroso J, Tubiana M. Radioiodine treatment in differentiated thyroid carcinomas Treatment of first local recurrences and of bone and lung metastases. Ann Radiol 1977; 20 783-6.
13. Brown A P, Greening W P, McCready V R, Shaw H J, Hamner C L. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984; 57:323-7.
14. Harmer C L. Unsealed radioactive isotopes in treatment. Nursing Times 1979 December; 20-27 41-4
15. Flower M A, Schlesinger T, Hinton P J, Adam I, Masoomi A M, Elbelli M A, et al. Radiation dose assessment in radioiodine therapy 2 Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol 1989, 15.345-57.
16. O'Connell M E Treatment outcome and radioiodine dose-response in differentiated thyroid carcinoma [thesis]. Univ of London, 1992.
17. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid cancers. Cancer 1985; 55 2062-71.
18. Black E G, Cassoni A, Gimlette T M D. Serum thyroglobulin in thyroid cancer. Lancet 1981, ii:443-5.
19. Powell M E B, Moskovic E C, Harmer C L Surveillance after treatment for well differentiated thyroid cancer: Audit for chest radiography. Clin Oncol 1994; 6:151-3.
20. O'Connell M E A, A'Hern R P, Harmer C L. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 1994; 30A:733-9.
21. Harmer C L. External beam therapy for thyroid cancer. Ann Radiol 1977; 20:791-800.
22. Hoskin P J, Harmer C L. Chemotherapy for thyroid cancer. Radiother Oncol 1987; 10:187-94.
23. Tissel L E, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986; 99:60-6
24. Ball A B S, Taif D M, Fisher C, Sinnett H D, Harmer C L. Treatment of metastatic para-aortic paraganglioma by surgery, radiotherapy and I-131 mIBG. Eur J Surg Oncol 1991; 17:543-6.
25. Schlumberger M, Gardet P, de Vathaire F, Sarrazin D, Travagli J P, Parmentier C External radiotherapy and chemotherapy in MTC patients. In: Calmettes C, Guliana J M, editors. Medullary Thyroid Carcinoma. Colloque INSERM London: John Libbey Eurotext Ltd, 1991; 211:213-20.
26. Tupchong L, Hughes F, Harmer C L. Primary lymphoma of the thyroid: Clinical features, prognostic factors, and results of treatment. Int J Radiat Oncol Biol Phys 1986; 12 1813-21.
27. Laing R W, Hoskin P, Vaughan Hudson B, Vaughan Hudson G, Harmer C L, Bennett M H, et al. The significance of MALT histology in thyroid lymphoma: A review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol 1994; 6:300-4.
28. Evans T R J, Mansi J L, Bevan D H, Dalgleish A G, Harmer C L. Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation Clin Oncol 1995; 7:54-5.